Last checked · How I check · Follow this CEO
Max Noble
Embla Medical
Sveinn Sölvason promised 5–8% sales growth. Delivered: about 5%.
5–8% more sales
Sveinn Sölvason, President & CEO, on 3 February 2026.
He gotAbout 5%
Stamp: Partly kept.
Why, says the companyIts clinics sold less than planned, and it lost a contract in Sweden. The profit promise held.
How badBig miss. Only the bottom of the promise, after three cuts. The CEO’s Integrity Score went from 0.0 to +4.4.
In the company’s own wordsPatient Care sales were below the expectations set at the start of the year, slowed by integration work in its clinics and a lost regional tender in Sweden. The margin promise held, helped by cost control.
The sourcesLast checked 1 November 2026: the sources were opened again and the promise and the stamp still stand. How I check.
How the Max Noble Odds movedOdds: 55% before the first call → verdict on 2 February 2027
The chance of Yes to “Will Embla grow its sales by about 5% in 2026, as promised?” The first number is my starting estimate; every call moves it. One point a day is kept from 8 November 2026 to the verdict.
Will Embla grow its sales by about 5% in 2026, as promised? Make your call in The Power Game →
Get an email the morning Sveinn Sölvason’s card turns.
One email when the stamp changes or a new promise is checked. Nothing else.